III

MENDUS AB

No trades
See on Supercharts
Market capitalization
‪513.67 M‬SEK
−0.2560SEK
‪−101.62 M‬SEK
‪848.71 M‬
Beta (1Y)
1.06

About MENDUS AB

CEO
Erik Manting
Website
Headquarters
Stockholm
Founded
2002
ISIN
SE0005003654
FIGI
BBG004G0BR10
Mendus AB is a biomedical company, which engages in the development of cancer immunotherapies. Its product pipeline includes INTUVAX, SUBCUVAX, and CD70. The company was founded by Bengt Anders Andersson, Alex Karlsson-Parra and AnnaCarin Wallgren in 2002 and is headquartered in Stockholm, Sweden.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of IMMU is 0.5090 SEK — it has decreased by 0.20% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange MENDUS AB stocks are traded under the ticker IMMU.
MENDUS AB is going to release the next earnings report on May 17, 2024. Keep track of upcoming events with our Earnings Calendar.
IMMU stock is 3.85% volatile and has beta coefficient of 1.06. Check out the list of the most volatile stocks — is MENDUS AB there?
One year price forecast for MENDUS AB has a max estimate of 1.8000 SEK and a min estimate of 0.7000 SEK.
Yes, you can track MENDUS AB financials in yearly and quarterly reports right on TradingView.
IMMU stock has fallen by 2.49% compared to the previous week, the month change is a 13.36% rise, over the last year MENDUS AB has showed a 71.44% decrease.
IMMU net income for the last quarter is ‪−41.17 M‬ SEK, while the quarter before that showed ‪−26.40 M‬ SEK of net income which accounts for −55.93% change. Track more MENDUS AB financial stats to get the full picture.
Today MENDUS AB has the market capitalization of ‪513.67 M‬, it has increased by 3.27% over the last week.
No, IMMU doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, IMMU shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MENDUS AB stock right from TradingView charts — choose your broker and connect to your account.
IMMU reached its all-time high on Dec 5, 2013 with the price of 41.9210 SEK, and its all-time low was 0.3000 SEK and was reached on Aug 31, 2023.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MENDUS AB technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MENDUS AB stock shows the sell signal. See more of MENDUS AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on MENDUS AB future price: according to them, IMMU price has a max estimate of 1.80 SEK and a min estimate of 0.70 SEK. Read a more detailed MENDUS AB forecast: see what analysts think of MENDUS AB and suggest that you do with its stocks.